Today's Daily Dose brings you news about IPOs of Crinetics Pharma and Rubius; secondary offerings of Cara, Oragenics and CytomX, and promising efficacy of Cellectar Biosciences' drug candidate CLR 131 observed in a single patient in a phase II trial.
from RTT - Biotech https://ift.tt/2NmRf06
via IFTTT
No comments:
Post a Comment